4 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic Participants With SchizophreniaSchizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophreniaNot yet recruitingPhase 22026-02-09NCT07396870
A Food Effect Study of LY03020 in Healthy SubjectsSchizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophreniaActive, not recruitingPhase 12025-12-18NCT07292233
A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophreniaRecruitingPhase 12025-11-19NCT07230652
Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathyActive, not recruitingPhase 32025-10-02NCT05531526